Chao Hu

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Epithelial Mesenchymal Transition

Inflammatory Response

Gene Expression

Top Venues

Molecules (Basel, Switzerland)

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Yan Luo, Guochen Zhang, Chao Hu, Lijun Huang, Dong Wang, Zhejie Chen, Yumei Wang
The Role of Natural Products from Herbal Medicine in TLR4 Signaling for Colorectal Cancer Treatment. Molecules (Basel, Switzerland) 29 (12) (2024)
Yan Luo, Guochen Zhang, Chao Hu, Lijun Huang, Dong Wang, Zhejie Chen, Yumei Wang
The Role of Natural Products from Herbal Medicine in TLR4 Signaling for Colorectal Cancer Treatment. Molecules (Basel, Switzerland) 29 (12) (2024)
Yan Luo, Guochen Zhang, Chao Hu, Lijun Huang, Dong Wang, Zhejie Chen, Yumei Wang
The Role of Natural Products from Herbal Medicine in TLR4 Signaling for Colorectal Cancer Treatment. Molecules (Basel, Switzerland) 29 (12) (2024)
Peng Peng, Xiaoyan Qiang, Guoyu Li, Lin Li, Shumao Ni, Qi Yu, Laura Sourd, Elisabetta Marangoni, Chao Hu, Dong Wang, Di Wu, Frank Wu
Tinengotinib (TT-00420), a Novel Spectrum-Selective Small Molecule Kinase Inhibitor, Is Highly Active Against Triple Negative Breast Cancer. Molecular cancer therapeutics (2022)